NORD - National Organization for Rare Disorders, Inc.

• Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,150 diseases.

• Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

• Rare Disease Database

Search this database for reports on more than 1,150 diseases.

View sample report

• Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

• Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

NORD Corporate Council

NORD® Corporate Council Members 2008
NORD is grateful to the following companies who are active members of the Corporate Council

Accredo Health, Inc.
Acorda Therapeutics
Actelion Pharmaceuticals US, Inc.
Alexion Pharmaceuticals, Inc.
Allergan
Altus Pharmaceuticals
Amicus Therapeutics, Inc.
Antigenics, Inc.
Applied Genetic Technologies Corp.
Aspreva Pharmaceuticals
Astra Zeneca Pharmaceuticals LP
Aton Pharma Inc
Avigen, Inc.
Bausch & Lomb Pharmaceuticals
Bausch & Lomb Surgical Division Retina Marketing
BioMarin Pharmaceuticals, Inc.
Brushcreek LLC/Errant Gene Therapeutics
Celgene Corporation
Duchesnay, Inc.
Endo Pharmaceuticals
Engage Health, Inc.
FFF Enterprises
FoldRX Pharmaceuticals, Inc.
Genzyme Therapeutics
Hemophelia Health Services
HPS Group LLC
Hyperion Therapeutics
IDIS Pharmaceuticals
Impax Laboratories, Inc.
IKARIA
Insmed Incorporated
Jazz Pharmaceuticals
Johnson & Johnson
Mark Krueger & Associates, Inc.
Medtronic, Inc.
Millennium Pharmaceuticals
Neurochem, Inc.
NexGenix Pharmaceuticals
Prestwick Pharmaceuticals
PTC Therapeutics Inc
Purdue Pharma
Questcor Pharmaceuticals, Inc.
Rare Disease Therapeutics, Inc.
Sanofi-Aventis, Inc.
Shire Pharmaceuticals
Sigma-Tau Pharmaceuticals
Ucyclyd Pharma (Medicis)
United Therapeutics Corporation
ZioPharm Oncology, Inc.

For information on the NORD Corporate Council please contact:
Jean Campbell, Vice President of Development
National Organization for Rare Disorders (NORD)
55 Kenosia Avenue Danbury, CT 06813
Phone - 203-744-0100
Fax - 203-798-2293
email - jcampbell@rarediseases.org

back to Corporate Council Homepage

ABOUT | CONTACT NORD

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

Last modified Tuesday, August 28, 2007